Found: 21
Select item for more details and to access through your institution.
Impact of First Line Antiangiogenic Therapy Duration on Nivolumab Outcome in Metastatic Renal Cell Carcinoma Patients Treated in the GETUG--AFU 26 NIVOREN.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 6, p. 643, doi. 10.1016/j.clgc.2023.07.008
- By:
- Publication type:
- Article
Activity of Systemic Treatments After Cabozantinib Failure in Advanced Metastatic Renal Cell Carcinoma.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 1, p. 80, doi. 10.1016/j.clgc.2021.09.001
- By:
- Publication type:
- Article
Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 6, p. 1807, doi. 10.1007/s10637-020-00945-y
- By:
- Publication type:
- Article
PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer.
- Published in:
- Drugs, 2022, v. 82, n. 7, p. 719, doi. 10.1007/s40265-022-01703-5
- By:
- Publication type:
- Article
Immunomodulatory Roles of VEGF Pathway Inhibitors in Renal Cell Carcinoma.
- Published in:
- Drugs, 2020, v. 80, n. 12, p. 1169, doi. 10.1007/s40265-020-01327-7
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma.
- Published in:
- Drugs, 2018, v. 78, n. 14, p. 1443, doi. 10.1007/s40265-018-0970-y
- By:
- Publication type:
- Article
Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920978134
- By:
- Publication type:
- Article
Tyrosine kinase inhibitors and immunotherapy combinations in renal cell carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920907504
- By:
- Publication type:
- Article
Sarcomatoid Dedifferentiation in Renal Cell Carcinoma: From Novel Molecular Insights to New Clinical Opportunities.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 99, doi. 10.3390/cancers12010099
- By:
- Publication type:
- Article
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00648-0
- By:
- Publication type:
- Article
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00648-0
- By:
- Publication type:
- Article
Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-57534-5
- By:
- Publication type:
- Article
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 6, p. 961, doi. 10.1038/s41416-024-02585-y
- By:
- Publication type:
- Article
Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers.
- Published in:
- World Journal of Urology, 2022, v. 40, n. 6, p. 1317, doi. 10.1007/s00345-021-03746-x
- By:
- Publication type:
- Article
Circulating and intratumoral immune determinants of response to atezolizumab plus bevacizumab in patients with variant histology or sarcomatoid renal cell carcinoma.
- Published in:
- Oncologist, 2023, v. 28, p. S15, doi. 10.1093/oncolo/oyad216.026
- By:
- Publication type:
- Article
The Effect of Concomitant Proton Pump Inhibitor and Cabozantinib on the Outcomes of Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 389, doi. 10.1002/onco.13711
- By:
- Publication type:
- Article
Characteristics of BRAF<sup>V600E</sup> Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. e1331, doi. 10.1634/theoncologist.2018-0914
- By:
- Publication type:
- Article
Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinoma.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2022, v. 13, n. 5, p. 2405, doi. 10.1002/jcsm.13021
- By:
- Publication type:
- Article
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 12, p. 1605, doi. 10.1093/jnci/djad155
- By:
- Publication type:
- Article
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21068-9
- By:
- Publication type:
- Article